MOTIVISTA Trademark

Trademark Overview


On Monday, January 20, 2025, a trademark application was filed for MOTIVISTA with the United States Patent and Trademark Office. The USPTO has given the MOTIVISTA trademark a serial number of 79420995. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, May 13, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The MOTIVISTA trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable computer software and downloadable mobile applications for assisting patients with symptoms of central nervous system diseases and disorders by providing lessons and techniques to treat and manage negative symptoms; downloadable computer software and downloadable mobile applications to assist patients with mental illness and disorders by providing lessons and techniques to treat and manage negative symptoms.

Therapeutic healthcare services for patients with symptoms of diseases and disorders of the central nervous system; therapeutic healthcare services for patients to support mental health.
motivista

General Information


Serial Number79420995
Word MarkMOTIVISTA
Filing DateMonday, January 20, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, May 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDownloadable computer software and downloadable mobile applications for assisting patients with symptoms of central nervous system diseases and disorders by providing lessons and techniques to treat and manage negative symptoms; downloadable computer software and downloadable mobile applications to assist patients with mental illness and disorders by providing lessons and techniques to treat and manage negative symptoms.
Goods and ServicesTherapeutic healthcare services for patients with symptoms of diseases and disorders of the central nervous system; therapeutic healthcare services for patients to support mental health.

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, April 21, 2025
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 21, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events


Event DateEvent Description
Monday, April 21, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, April 10, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, April 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 23, 2025APPLICATION FILING RECEIPT MAILED
Thursday, May 8, 2025ASSIGNED TO EXAMINER
Wednesday, May 14, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 13, 2025NON-FINAL ACTION WRITTEN